-
公开(公告)号:EP3215153A4
公开(公告)日:2018-01-24
申请号:EP15857812
申请日:2015-11-05
发明人: BECK HILARY PLAKE , JAEN JUAN CARLOS , OSIPOV MAKSIM , POWERS JAY PATRICK , REILLY MAUREEN KAY , SHUNATONA HUNTER PAUL , WALKER JAMES ROSS , ZIBINSKY MIKHAIL , BALOG JAMES AARON , WILLIAMS DAVID K , MARKWALDER JAY A , CHERNEY EMILY CHARLOTTE , SHAN WEIFANG , HUANG AUDRIS
IPC分类号: A61K31/4375 , A61K31/4709 , A61K31/496 , C07D215/14 , C07D215/233 , C07D217/04 , C07D231/56 , C07D239/74 , C07D401/12 , C07D401/14 , C07D405/12 , C07D471/04 , C07D487/04
CPC分类号: C07D487/04 , A61K31/416 , A61K31/437 , A61K31/4375 , A61K31/47 , A61K31/4709 , A61K31/496 , A61K31/506 , A61K31/517 , A61K31/519 , A61K45/06 , C07D215/06 , C07D215/14 , C07D215/233 , C07D217/04 , C07D231/56 , C07D239/74 , C07D401/12 , C07D401/14 , C07D405/08 , C07D405/12 , C07D417/08 , C07D417/12 , C07D471/04
摘要: Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.
-
公开(公告)号:EP3215141A4
公开(公告)日:2018-06-06
申请号:EP15856241
申请日:2015-11-05
发明人: BECK HILARY PLAKE , JAEN JUAN CARLOS , OSIPOV MAKSIM , POWERS JAY PATRICK , REILLY MAUREEN KAY , SHUNATONA HUNTER PAUL , WALKER JAMES ROSS , ZIBINSKY MIKHAIL , BALOG JAMES AARON , WILLIAMS DAVID K , GUO WEIWEI
CPC分类号: A61K31/195 , A61K31/167 , A61K31/426 , A61K39/39 , A61K45/06 , A61K2039/55511 , A61P35/00 , C07C233/15 , C07C233/29 , C07C233/66 , C07C235/26 , C07C235/36 , C07C235/38 , C07C237/20 , C07C237/22 , C07C255/57 , C07C255/60 , C07C317/40 , C07C317/44 , C07C321/28 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07D207/27 , C07D213/56 , C07D213/75 , C07D231/12 , C07D239/42 , C07D277/30 , C07D295/15 , C07D295/155 , C07D309/04 , C07D309/06 , C07D317/46 , Y02A50/41 , Y02A50/412 , A61K2300/00
摘要: Compounds that modulate the oxidoreductase enzyme indoleamine 2,3- dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune -related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.
-